Gerald E. Quirk
CIK: 0001479603
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Syros Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Gerald E. Quirk files insider reports with the SEC as Chief Legal & Compliance Offic of Syros Pharmaceuticals, Inc. (SYRS). Signal8 holds 3 reported Form 4/5 transactions by Gerald E. Quirk since Sep 2024. The most recent reported transaction is a sale (Form 4 code S) in SYRS, dated Nov 19, 2024.
About Quirk Gerald E
Quirk Gerald E (SEC CIK 0001479603) files insider reports with the SEC as Chief Legal & Compliance Offic of Syros Pharmaceuticals, Inc. (SYRS).
Signal8 holds 2 ownership filings by Quirk Gerald E, all Form 4s, filed between Oct 2, 2024 and Nov 20, 2024. Those filings report 3 transactions, from Sep 30, 2024 to Nov 19, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Quirk Gerald E's filings is in CAMBRIDGE, MA.
Recent filings by Quirk Gerald E
Other insiders filing for Syros Pharmaceuticals, Inc. (SYRS)
- Simonian Nancy A, Director
- Stephens Kristin, Chief Development Officer
- Roth David, Chief Medical Officer
- Chee Conley, President & CEO
- Haas Jason, Chief Financial Officer
- AKKARAJU SRINIVAS, Director